These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4164027)

  • 1. A cytocidal system in normal human serum active against Ehrlich Lettré ascites tumor cells. I. Identification of the components of the system and site of attachment.
    Hotham-Iglewski B; Ludwig EH
    Cancer Res; 1967 Jan; 27(1):181-4. PubMed ID: 4164027
    [No Abstract]   [Full Text] [Related]  

  • 2. The cytocidal action of normal human serum on Ehrlich Lettré ascites tumor cells. II. Biochemical studies.
    Hotham-Iglewski B; Ludwig EH
    Cancer Res; 1967 Jan; 27(1):185-90. PubMed ID: 6067001
    [No Abstract]   [Full Text] [Related]  

  • 3. A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
    Goff MM; Armentrout SA
    J Clin Lab Immunol; 1982 Dec; 9(3):163-7. PubMed ID: 7166749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of mouse gamma globulin on the lysis of isologous mouse tumour cells by human serum.
    Hartveit F
    Acta Pathol Microbiol Scand; 1966; 68(1):29-36. PubMed ID: 4162990
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histochemical studies on the effect of antibody and serum factors on ascites tumor cells and mast cells].
    Keller R
    Bibl Haematol; 1967; 27():95-101. PubMed ID: 4233209
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proteins of the cells of ascites carcinoma studied with immunofluorescence, electrophoresis and immunoelectrophoresis].
    Raimondi L; Pagani G
    Folia Allergol (Roma); 1966; 13(5):371-3. PubMed ID: 4870705
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzymatic degradation of tumor cells damaged by antibody plus complement.
    Reif AE; Robinson CM
    J Immunol; 1976 Aug; 117(2):597-601. PubMed ID: 985839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of membrane proteins related to anion transport in Ehrlich ascites tumor cells.
    Hoffmann EK; Sjøholm C; Uerkvitz W
    Tokai J Exp Clin Med; 1982; 7 Suppl():103-11. PubMed ID: 7186216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin (Adriamycin) transport in Ehrlich ascites tumour cells: comparison with transport in human red blood cells.
    Dalmark M; Hoffmann EK
    Scand J Clin Lab Invest; 1983 May; 43(3):241-8. PubMed ID: 6312556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of antibodies in rats in response to xenogeneic grafts of Ehrlich ascites tumor by the fluorescent antibody technique.
    Dux K; Skurzak H
    Arch Immunol Ther Exp (Warsz); 1969; 17(1):1-7. PubMed ID: 4179817
    [No Abstract]   [Full Text] [Related]  

  • 11. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
    Sur P; Nandi N; Ghosh P; Ghosh NC
    Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topography of concanavalin A receptors on Ehrlich ascites tumour cells as demonstrated by thin sections and freeze etching.
    Roth J; Wagner M; Meyer HW
    Pathol Eur; 1974; 9(1):31-42. PubMed ID: 4608187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoelectron microscopic localization of receptors with terminal N-acetyl-D-galactosamine on the surface of Ehrlich ascites tumor cells using the protection of Helix pomatia (author's transl)].
    Wagner M; Wagner B
    Z Immunitatsforsch Exp Klin Immunol; 1973 Dec; 146(3):274-82. PubMed ID: 4282980
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface antigen on Ehrlich ascites tumor cells.
    Pessina A; Brambilla P; Mocarelli P
    Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of cytotoxicity of rabbit anti-Ehrlich ascites tumor cell antibody following pepsin digestion.
    Whitehouse F; Kilduff JT
    J Immunol; 1966 Sep; 97(3):386-92. PubMed ID: 5332651
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular transport mechanisms for 57Co-bleomycin].
    Metelmann HR; Bier J; Bitter K
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):99-101. PubMed ID: 6157514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural antibodies against the Ehrlich ascites mouse tumour in sera of irradiated goats, identified by complement consumption.
    Oravec C; Cambelová J
    Neoplasma; 1971; 18(2):161-72. PubMed ID: 5577314
    [No Abstract]   [Full Text] [Related]  

  • 20. CYTOCIDAL EFFECT OF CHLOROFORM-ACTIVATED SERUM ON ASCITES TUMOR CELLS.
    APFFEL CA
    J Natl Cancer Inst; 1963 Oct; 31():827-39. PubMed ID: 14069830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.